XTEK Ltd's (ASX:XTE) managing director Phillipe Odouard speaks to Proactive soon after signing an agreement with KeyOptions Pty Ltd to exclusively distribute and support Virolens, which is designed to screen for SARS-CoV-2 in around 20-30 seconds, in Australia, New Zealand and the Pacific independent states. The Virolens system is a COVID-19 screening device based on microscopic holographic imaging and artificial intelligence (AI) software technology.
XTEK Ltd details exclusive distribution deal for COVID-19 screening device Virolens
